Jason Austin, DO
Family Medicine · Johnston, RINPI 1013963818
Payments from drug & device makers
Across 705 payments — averaging $20.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$2K
- AstraZeneca$2K
- GSK$1K
- Pfizer$1K
- Vanda Pharmaceuticals Inc.$838
- plus $6K from 54 others
What the payments were for
- Food & beverage$14,66299%
- Education$991%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$355
- COLOGUARD$250
- LOKELMA$126
- EUCRISA$124
- FREESTYLE LIBRE 3$121
- INVOKANA$114
- VRAYLAR$114
- AIRSUPRA$104
- TRELEGY ELLIPTA$103
How this compares
$14,761 in reported general payments places this provider in the 95th percentile of 222 family medicine providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 84 | $97,718 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 99 | $71,020 |
| OzempicSemaglutide | 39 | $44,904 |
| JardianceEmpagliflozin | 36 | $44,107 |
| XareltoRivaroxaban | 16 | $25,092 |
| VraylarCariprazine Hcl | 12 | $18,048 |
| EntrestoSacubitril/Valsartan | 17 | $17,347 |
| LinzessLinaclotide | 18 | $16,810 |
| TrulicityDulaglutide | 11 | $12,747 |
| MyrbetriqMirabegron | 18 | $11,145 |
| TradjentaLinagliptin | 19 | $9,202 |
| Atorvastatin Calcium | 846 | $8,466 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $8,423 |
| GemtesaVibegron | 13 | $6,202 |
| Omeprazole | 350 | $5,688 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $1,324 | $97,71884 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $1,333 | $75,936117 claims |
| Boehringer IngelheimJardiance, Tradjenta | $122 | $53,30955 claims |
| Novo NordiskOzempic | $405 | $44,90439 claims |
| AbbVieVraylar, Linzess, Lumigan | $1,981 | $37,90541 claims |
| Johnson & JohnsonXarelto | $1,600 | $25,09216 claims |
| NovartisEntresto | $491 | $17,34717 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,534 | $12,90032 claims |
| Lilly USA, LLCTrulicity | $90 | $12,74711 claims |
| Astellas Pharma US IncMyrbetriq | $299 | $11,14518 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $62 | $6,20213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 222 family medicine providers in Rhode Island.
Other family medicine in Johnston
- Wilfredo Giordano-PerezJohnston$351K
- Constantine VafidisJohnston$9K
- Gina la ProvaCumberland$778K
- Richard GocciaCoventry$561K
- Mark TurshenWarwick$249K
- Lauren HeddeNorth Kingstown$157K
- Martin MinerProvidence$124K
- Charles EatonPawtucket$118K
- Patrick MalloyWarwick$19K
- Frank la FaziaWest Warwick$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.